Fidaxomicin to prevent recurrent Clostridioides difficile: what will it cost in the USA and Canada?

IMPORTANCE: Recent changes in guidelines for managing Clostridioides difficile infections (CDI) have placed fidaxomicin as a first-line treatment. OBJECTIVE: To estimate the net cost of first-line fidaxomicin compared to vancomycin in the American and Canadian healthcare systems and to estimate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Devangi, Senecal, Julien, Spellberg, Brad, Morris, Andrew M, Saxinger, Lynora, Footer, Brent W, McDonald, Emily G, Lee, Todd C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825808/
https://www.ncbi.nlm.nih.gov/pubmed/36632358
http://dx.doi.org/10.1093/jacamr/dlac138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825808/
https://www.ncbi.nlm.nih.gov/pubmed/36632358
http://dx.doi.org/10.1093/jacamr/dlac138

Ejemplares similares